急性中毒昏迷患者非侵入性气道管理效果:一项随机临床试验
这项多中心随机试验在法国20个急诊科和1个ICU纳入225例疑似急性中毒且GCS<9的昏迷患者,比较保守气道策略(不插管)与常规实践。干预组插管比例16%,对照组58%。主要终点为住院死亡、ICU停留时间和住院时间的分层复合终点,干预组胜率1.85(95%CI 1.33-2.58)。干预组任何不良事件比例6% vs 14.7%(绝对风险差-8.6%,95%CI -16.6%至-0.7%),肺炎发生率6.9% vs 14.7%(绝对风险差-7.8%,95%CI -15.9%至0.3%)。两组均无住院死亡。
要点
- 疑似急性中毒且GCS<9的昏迷患者中,保守气道策略(不插管)组插管率16%,常规实践组58%。
- 主要复合终点(住院死亡、ICU停留时间、住院时间)干预组胜率1.85(95%CI 1.33-2.58)。
- 干预组任何不良事件6% vs 对照组14.7%,绝对风险差-8.6%(95%CI -16.6%至-0.7%)。
- 肺炎发生率干预组6.9%(8例)vs 对照组14.7%(16例),绝对风险差-7.8%(95%CI -15.9%至0.3%)。
- 住院期间无患者死亡。
适用人群与场景
- 疑似急性中毒且Glasgow昏迷评分<9的昏迷患者,纳入法国20个急诊科和1个ICU,2021年5月16日至2023年4月12日。
诊断标准与关键阈值
- Glasgow昏迷评分<9。
处置流程与药物剂量
- 保守气道策略:不插管;干预组插管率16%,对照组58%。
研究设计与关键结果
- 多中心随机试验,纳入225例患者(平均年龄33岁,女性38%),干预组116例,对照组109例。
- 主要终点为住院死亡、ICU停留时间和住院时间的分层复合终点,干预组胜率1.85(95%CI 1.33-2.58)。
- 任何不良事件:干预组6% vs 对照组14.7%,绝对风险差-8.6%(95%CI -16.6%至-0.7%)。
- 肺炎:干预组8例(6.9%)vs 对照组16例(14.7%),绝对风险差-7.8%(95%CI -15.9%至0.3%)。
- 住院期间无患者死亡。
证据类型、等级与局限
- 随机临床试验;局限:原文未报告局限性。
对床旁实践的改变
- 在疑似急性中毒且GCS<9的昏迷患者中,保守气道策略(不插管)与复合终点(住院死亡、ICU停留时间、住院时间)的临床获益相关。
指南或共识出处
- ClinicalTrials.gov Identifier: NCT04653597
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Tracheal intubation is recommended for coma patients and those with severe brain injury, but its use in patients with decreased levels of consciousness from acute poisoning is uncertain.
OBJECTIVE: To determine the effect of intubation withholding vs routine practice on clinical outcomes of comatose patients with acute poisoning and a Glasgow Coma Scale score less than 9.
DESIGN, SETTING, AND PARTICIPANTS: This was a multicenter, randomized trial conducted in 20 emergency departments and 1 intensive care unit (ICU) that included comatose patients with suspected acute poisoning and a Glasgow Coma Scale score less than 9 in France between May 16, 2021, and April 12, 2023, and followed up until May 12, 2023.
INTERVENTION: Patients were randomized to undergo conservative airway strategy of intubation withholding vs routine practice.
MAIN OUTCOMES AND MEASURES: The primary outcome was a hierarchical composite end point of in-hospital death, length of ICU stay, and length of hospital stay. Key secondary outcomes included adverse events resulting from intubation as well as pneumonia within 48 hours.
RESULTS: Among the 225 included patients (mean age, 33 years; 38% female), 116 were in the intervention group and 109 in the control group, with respective proportions of intubations of 16% and 58%. No patients died during the in-hospital stay. There was a significant clinical benefit for the primary end point in the intervention group, with a win ratio of 1.85 (95% CI, 1.33 to 2.58). In the intervention group, there was a lower proportion with any adverse event (6% vs 14.7%; absolute risk difference, 8.6% [95% CI, -16.6% to -0.7%]) compared with the control group, and pneumonia occurred in 8 (6.9%) and 16 (14.7%) patients, respectively (absolute risk difference, -7.8% [95% CI, -15.9% to 0.3%]).
CONCLUSIONS AND RELEVANCE: Among comatose patients with suspected acute poisoning, a conservative strategy of withholding intubation was associated with a greater clinical benefit for the composite end point of in-hospital death, length of ICU stay, and length of hospital stay.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04653597.
参考来源
- Freund Y, Viglino D, Cachanado M, et al. Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial. JAMA. 2023. PMID: 38019968. doi:10.1001/jama.2023.24391
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。